-
Adenosine A2A and A2B Receptor Substantially Attenuate Ischemia/Reperfusion Injury in Septic rat Hearts.
Cardiovascular drugs and therapy 20160101
-
Adenosine A2A receptor as a drug discovery target.
Journal of medicinal chemistry 20140508
-
Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells.
Journal of immunology (Baltimore, Md. : 1950) 20131215
-
Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
American journal of physiology. Regulatory, integrative and comparative physiology 20130101
-
Adenosine A2a receptor induces GDNF expression by the Stat3 signal in vitro.
Neuroreport 20121114
-
Selective blockade of A(2A) receptor protects against neurotoxicity induced by kainic acid in young rats.
Fundamental & clinical pharmacology 20120801
-
Characterization of the Drosophila adenosine receptor: the effect of adenosine analogs on cAMP signaling in Drosophila cells and their utility for in vivo experiments.
Journal of neurochemistry 20120501
-
SCH58261 the selective adenosine A(2A) receptor blocker modulates ischemia reperfusion injury following bilateral carotid occlusion: role of inflammatory mediators.
Neurochemical research 20120301
-
Distinctive immunoregulatory effects of adenosine on T cells of older humans.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20120301
-
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
Bioorganic & medicinal chemistry 20120115
-
A novel fused 1,2,4-triazine aryl derivative as antioxidant and nonselective antagonist of adenosine A(2A) receptors in ethanol-activated liver stellate cells.
Chemico-biological interactions 20120105
-
Enhanced IL-6 transcriptional response to adenosine receptor ligands in horses with lower airway inflammation.
Equine veterinary journal 20120101
-
Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion.
Neurobiology of disease 20120101
-
Combined contribution of endothelial relaxing autacoides in the rat femoral artery response to CPCA: an adenosine A2 receptor agonist.
TheScientificWorldJournal 20120101
-
Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake.
Journal of Alzheimer's disease : JAD 20120101
-
Blockade of adenosine A2A receptors prevents interleukin-1β-induced exacerbation of neuronal toxicity through a p38 mitogen-activated protein kinase pathway.
Journal of neuroinflammation 20120101
-
Adenosine reduces cell surface expression of toll-like receptor 4 and inflammation in response to lipopolysaccharide and matrix products.
Journal of cardiovascular translational research 20111201
-
Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus.
Epilepsy & behavior : E&B 20111001
-
[Protective effect of new adenosine analog B2 against serum deprivation-induced PC12 cell injury].
Yao xue xue bao = Acta pharmaceutica Sinica 20111001
-
Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing.
The European journal of neuroscience 20110701
-
Adenosine A2A receptor induces protein kinase A-dependent functional modulation of human (alpha)3(beta)4 nicotinic receptor.
The Journal of physiology 20110601
-
[Sedative, hypnotic and anticonvulsive effects of an adenosine analogue WS090501].
Yao xue xue bao = Acta pharmaceutica Sinica 20110601
-
Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats.
Experimental gerontology 20110401
-
Novel 8-(furan-2-yl)-3-benzyl thiazolo [5,4-e][1,2,4] triazolo [1,5-c] pyrimidine-2(3H)-thione as selective adenosine A(2A) receptor antagonist.
Neuroscience letters 20110113
-
Involvement of adenosine signaling in controlling the release of ghrelin from the mouse stomach.
The Journal of pharmacology and experimental therapeutics 20110101
-
Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects.
Journal of neuroinflammation 20110101
-
Caffeine acts via A1 adenosine receptors to disrupt embryonic cardiac function.
PloS one 20110101
-
Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells.
The Journal of biological chemistry 20101217
-
Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels.
Microcirculation (New York, N.Y. : 1994) 20101101
-
Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.
American journal of physiology. Renal physiology 20100801
-
Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation.
Journal of immunology (Baltimore, Md. : 1950) 20100715
-
Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo.
Cellular and molecular neurobiology 20100401
-
Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A(2A) receptor antagonists.
Bioorganic & medicinal chemistry 20100401
-
Glutamate-induced depression of EPSP-spike coupling in rat hippocampal CA1 neurons and modulation by adenosine receptors.
The European journal of neuroscience 20100401
-
CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
Cancer research 20100315
-
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
Neuropharmacology 20100301
-
Adenosine up-regulates vascular endothelial growth factor in human macrophages.
Biochemical and biophysical research communications 20100212
-
Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
Pharmacology, biochemistry, and behavior 20100201
-
The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice.
Neuroscience letters 20100122
-
Remodeling of striatal NMDA receptors by chronic A(2A) receptor blockade in Huntington's disease mice.
Neurobiology of disease 20100101
-
Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life.
Journal of neurochemistry 20100101
-
Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.
Journal of biomedical science 20100101
-
Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease.
Journal of neurochemistry 20091201
-
Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20091125
-
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
Journal of immunology (Baltimore, Md. : 1950) 20091115
-
Differential effects of adenosine antagonists in two models of parkinsonian tremor.
Pharmacology, biochemistry, and behavior 20091101
-
Adenosine A2a receptor induced gliosis via Akt/NF-kappaB pathway in vitro.
Neuroscience research 20091101
-
Absence of adenosine-mediated aortic relaxation in A(2A) adenosine receptor knockout mice.
American journal of physiology. Heart and circulatory physiology 20091101
-
Pharmacological modifications of the stretch-induced effects on ventricular fibrillation in perfused rabbit hearts.
American journal of physiology. Heart and circulatory physiology 20091101
-
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease.
The European journal of neuroscience 20090901
-
Adenosine receptor antagonists and behavioral activation in NF-kappaB p50 subunit knockout mice.
Life sciences 20090731
-
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.
Bioorganic & medicinal chemistry 20090715
-
Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression.
The Journal of pharmacology and experimental therapeutics 20090701
-
The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.
British journal of pharmacology 20090701
-
Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice.
Psychopharmacology 20090601
-
Adenosine A(2A) receptor modulation of hippocampal CA3-CA1 synapse plasticity during associative learning in behaving mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090601
-
Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia.
Brain : a journal of neurology 20090601
-
Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease.
Pharmacology, biochemistry, and behavior 20090501
-
Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors.
British journal of pharmacology 20090101
-
An adenosine A(2A) antagonist injected in the NTS reverses thermal prolongation of the LCR in decerebrate piglets.
Respiratory physiology & neurobiology 20081231
-
Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice.
American journal of physiology. Heart and circulatory physiology 20081101
-
Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice.
Experimental neurology 20080901
-
2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Journal of medicinal chemistry 20080814
-
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists.
Bioorganic & medicinal chemistry letters 20080715
-
Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists.
Bioorganic & medicinal chemistry letters 20080715
-
Postsynaptic action of brain-derived neurotrophic factor attenuates alpha7 nicotinic acetylcholine receptor-mediated responses in hippocampal interneurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20080521
-
Caffeine and a selective adenosine A(2B) receptor antagonist but not imidazoline receptor antagonists modulate antinociception induced by diphenyl diselenide in mice.
Neuroscience letters 20080509
-
CNGA2 channels mediate adenosine-induced Ca2+ influx in vascular endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 20080501
-
Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
Synapse (New York, N.Y.) 20080501
-
Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine.
Neuropharmacology 20080501
-
Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.
Experimental neurology 20080401
-
Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats.
The international journal of neuropsychopharmacology 20080301
-
Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses.
Neuron 20080110
-
Brainstem phosphorylated extracellular signal-regulated kinase 1/2-nitric-oxide synthase signaling mediates the adenosine A2A-dependent hypotensive action of clonidine in conscious aortic barodenervated rats.
The Journal of pharmacology and experimental therapeutics 20080101
-
Effect of the pyridoindole SMe1EC2 and compounds affecting A(1) and A(2A) adenosine receptors in rat hippocampus under ischemia in vitro.
Pharmacological reports : PR 20080101
-
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
Neurobiology of disease 20071101
-
Transient inhibition of astrocytogenesis in developing mouse brain following postnatal caffeine exposure.
Pediatric research 20071101
-
Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus.
Neuroscience 20071012
-
Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Synapse (New York, N.Y.) 20070801
-
Determination of adenosine effects and adenosine receptors in murine corpus cavernosum.
The Journal of pharmacology and experimental therapeutics 20070801
-
A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and betagamma subunits formed after alpha2-adrenoceptor activation.
Neurochemistry international 20070701
-
Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration.
Journal of neuropathology and experimental neurology 20070501
-
Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
Naunyn-Schmiedeberg's archives of pharmacology 20070401
-
3H-[1,2,4]-Triazolo[5,1-i]purin-5-amine derivatives as adenosine A2A antagonists.
Bioorganic & medicinal chemistry letters 20070315
-
Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines.
Bioorganic & medicinal chemistry letters 20070301
-
Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model.
Journal of pharmacological sciences 20070301
-
Tonic adenosine A1 and A2A receptor activation is required for the excitatory action of VIP on synaptic transmission in the CA1 area of the hippocampus.
Neuropharmacology 20070201
-
A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20070201
-
Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Behavioural brain research 20070125
-
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
Experimental neurology 20070101
-
Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20061227
-
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
Journal of the neurological sciences 20061025
-
Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.
Brain research 20061003
-
Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress.
Neuroscience 20060915
-
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
Synapse (New York, N.Y.) 20060901
-
Evidence for both adenosine A1 and A2A receptors activating single vagal sensory C-fibres in guinea pig lungs.
The Journal of physiology 20060901
-
Central adenosine signaling plays a key role in centrally mediated hypotension in conscious aortic barodenervated rats.
The Journal of pharmacology and experimental therapeutics 20060701
-
Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
European journal of pharmacology 20060424
-
Adenosine receptors as therapeutic targets.
Nature reviews. Drug discovery 20060301
-
The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia.
Brain research 20060216
-
Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice.
European journal of pharmacology 20060215
-
Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060201
-
Hypoxia-induced desensitization and internalization of adenosine A1 receptors in the rat hippocampus.
Neuroscience 20060101
-
Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists.
Bioorganic & medicinal chemistry letters 20051101
-
Genetic and pharmacological inactivation of adenosine A2A receptor reveals an Egr-2-mediated transcriptional regulatory network in the mouse striatum.
Physiological genomics 20050921
-
Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery.
American journal of physiology. Heart and circulatory physiology 20050601
-
Adenosine A2A receptors control the extracellular levels of adenosine through modulation of nucleoside transporters activity in the rat hippocampus.
Journal of neurochemistry 20050501
-
6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.
Bioorganic & medicinal chemistry letters 20050415
-
Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
Journal of medicinal chemistry 20050324
-
Mediators of coronary reactive hyperaemia in isolated mouse heart.
British journal of pharmacology 20050201
-
Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum.
Journal of neurochemistry 20050201
-
Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists.
Bioorganic & medicinal chemistry letters 20050201
-
A2B adenosine receptor activity is reduced in neutrophils from patients with systemic sclerosis.
Arthritis research & therapy 20050101
-
Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat.
Neuroscience 20050101
-
Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists.
Journal of medicinal chemistry 20041202
-
Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells.
Journal of neurochemistry 20041201
-
Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination.
Basic & clinical pharmacology & toxicology 20041201
-
Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery.
European journal of pharmacology 20041103
-
Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A(2A) adenosine receptor blockade.
Neuropharmacology 20041101
-
Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles.
Bioorganic & medicinal chemistry letters 20041004
-
Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists.
Bioorganic & medicinal chemistry letters 20041004
-
Effect of free radicals on adenosine A(2A) and dopamine D2 receptors in the striatum of young adult and aged rats.
Neurochemistry international 20041001
-
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow.
Neurobiology of disease 20041001
-
Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
Experimental neurology 20040901
-
Facilitation of noradrenaline release by activation of adenosine A(2A) receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery.
Cardiovascular research 20040901
-
Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
Journal of medicinal chemistry 20040812
-
Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
Parkinsonism & related disorders 20040701
-
Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Journal of neuroscience research 20040701
-
Comparison of inhibitory activity of isomeric triazolopyridine derivatives towards adenosine receptor subtypes or do similar structures reveal similar bioactivities?
Bioorganic & medicinal chemistry letters 20040621
-
Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives.
Journal of medicinal chemistry 20040603
-
Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
Journal of neurochemistry 20040401
-
Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice.
British journal of pharmacology 20040301
-
Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities.
Neurology 20031209
-
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats.
Neurology 20031209
-
A2A receptors in neuroprotection of dopaminergic neurons.
Neurology 20031209
-
Modulation of glutamate release and excitotoxicity by adenosine A2A receptors.
Neurology 20031209
-
Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease.
Neurology 20031209
-
Adenosine A2A receptors and depression.
Neurology 20031209
-
Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade.
Neuropharmacology 20031201
-
Cyclopentyladenosine and some of its low-efficacy derivatives inhibit striatal synaptosomal release of acetylcholine to a similar degree.
European journal of pharmacology 20031128
-
Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes.
Glia 20030801
-
Interactive role of adenosine and dopamine in the opiate withdrawal syndrome.
Naunyn-Schmiedeberg's archives of pharmacology 20030801
-
Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease.
Brain research 20030725
-
SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
Brain research 20030711
-
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Journal of medicinal chemistry 20030327
-
Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices.
Neuroscience letters 20030320
-
Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats.
European journal of pharmacology 20030307
-
Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells.
Molecular pharmacology 20030201
-
The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat.
Brain research 20030110
-
Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats.
Polish journal of pharmacology 20030101
-
Transducing system operated by adenosine A(2A) receptors to facilitate acetylcholine release in the rat hippocampus.
European journal of pharmacology 20021101
-
SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices.
European journal of pharmacology 20020830
-
Effects of A(1) and A(2A) adenosine receptor ligands in mouse acute models of pain.
Neuroscience letters 20020816
-
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.
Nature 20020815
-
Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020801
-
Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20020801
-
Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
Synapse (New York, N.Y.) 20020601
-
Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.
British journal of pharmacology 20020601
-
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
The Journal of biological chemistry 20020419
-
Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20020301
-
Diverse inhibitors of intracellular signalling act as adenosine receptor antagonists.
Cellular signalling 20020201
-
Anoxia redistributes adenosine A(2A) receptors in PC12 cells and increases receptor-mediated formation of cAMP.
Naunyn-Schmiedeberg's archives of pharmacology 20020201
-
Blockade of A(2A) adenosine receptors leads to c-fos inhibition in a rat model of brain ischemia.
Pharmacological research 20020201
-
7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
Journal of medicinal chemistry 20020103
-
Adenosine A(2A) and A(2B) receptor activation of erythropoietin production.
American journal of physiology. Renal physiology 20011101
-
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
British journal of pharmacology 20011101
-
In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261.
The European journal of neuroscience 20011101
-
Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease.
Neurotoxicity research 20011101
-
Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.
British journal of pharmacology 20010901
-
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.
British journal of pharmacology 20010901
-
SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
Synapse (New York, N.Y.) 20010801
-
Production of leukotrienes in a model of focal cerebral ischaemia in the rat.
British journal of pharmacology 20010801
-
SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum.
European journal of pharmacology 20010615
-
Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20010515
-
Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
Synapse (New York, N.Y.) 20010301
-
Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201
-
Selective adenosine A2A receptor antagonists.
Farmaco (Societa chimica italiana : 1989) 20010101
-
Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine.
Molecular pharmacology 20001201
-
Anticonvulsant effect and neurotransmitter modulation of focal and systemic 2-chloroadenosine against the development of pilocarpine-induced seizures.
Neuropharmacology 20000901
-
Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
Biochemical pharmacology 19990101
-
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
Naunyn-Schmiedeberg's archives of pharmacology 19990101
-
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
British journal of pharmacology 19970501
-
The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
The Journal of pharmacology and experimental therapeutics 19960201
-
A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding.
The Journal of biological chemistry 19940128